Scholars Central

CommentaryPublished Jun 2011

Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment

Welcome to the Journal

Volume 1 · Issue 6 · Pages 771

More from this journal

The newest in Welcome to the Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalWelcome to the Journal
  • SubjectGeneral & Internal Medicine